Zoledronic acid therapy impacts risk and frequency of skeletal complications and follow-up duration in prostate cancer patients with bone metastasis.

Source:http://linkedlifedata.com/resource/pubmed/id/21083514

Download in:

View as

General Info

PMID
21083514